对内脏脂肪的代谢评分和慢性阻塞性肺病的不良结果之间的关联
Kai Ma1, Tianyi Xia2, Tao Liu3
1Department of Respiratory Medicine, Southeast University, Nanjing, China.
BMJ open respiratory research
|January 6, 2026
概括
内脏脂肪代谢评分 (METS-VF) 的升高与慢性阻塞性肺病 (COPD) 患者的死亡率和不良结果的增加有关. METS-VF可能有助于分层COPD患者的风险.
科学领域:
- 肺部医学 肺部医学
- 心血管医学 心血管医学
- 代谢健康 代谢健康
背景情况:
- 内脏脂肪的代谢评分 (METS-VF) 与慢性阻塞性肺病 (COPD) 发生率有关.
- 它在COPD死亡率和不良结果中的作用需要进一步调查.
研究的目的:
- 调查METS-VF与COPD患者的死亡率和不良结果之间的关联.
- 评估METS-VF作为COPD管理中的预后生物标志物.
主要方法:
- 对7246名英国生物库和869名美国NHANES参与者进行分析.
- METS-VF分为四分之一;结果包括所有原因,心血管疾病和COPD特异性死亡率,PHD,PE和HF.
- 使用了考克斯模型,受限立方线,ROC曲线和调解分析 (CRP,WBC,PLT).
主要成果:
- 在英国生物库中,最高的METS-VF四分位数显著增加了所有原因,心血管疾病,COPD死亡率,PHD,PE和HF的风险.
- 在所有原因和心血管疾病死亡率方面,NHANES证实了类似的关联.
- CRP和WBC部分调解了观察到的关联.
结论:
- 升高的METS-VF始终与COPD患者的长期死亡率和心肺并发症风险增加有关.
- METS-VF显示出作为COPD风险分层的实际预后生物标志物的潜力.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:29Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K